This protein promotes cancer growth and treatment resistance by activating signaling cascades involving the epidermal growth factor receptor (EGFR), erythroblastic oncogene B2 (ErbB2), and mesenchymal-epithelial transition (MET). The gene discussed is ERBB2; the disease is cancer.